Glucose Metabolic Reprogramming of ER(+) Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib

The majority of breast cancers express the estrogen receptor (ER) and are dependent on estrogen for their growth and survival. Endocrine therapy (ET) is the standard of care for these tumors. However, a superior outcome is achieved in a subset of ER positive (ER(+))/human epidermal growth factor rec...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cells
Main Authors: Lorito, Nicla, Bacci, Marina, Smiriglia, Alfredo, Mannelli, Michele, Parri, Matteo, Comito, Giuseppina, Ippolito, Luigi, Giannoni, Elisa, Bonechi, Martina, Benelli, Matteo, Migliaccio, Ilenia, Malorni, Luca, Chiarugi, Paola, Morandi, Andrea
格式: Artigo
語言:Inglês
出版: MDPI 2020
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7140692/
https://ncbi.nlm.nih.gov/pubmed/32164162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9030668
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍